ÂÜÀòÂÒÂ×

Brian Leuthner has extensive experience in the biotechnology and healthcare industries, currently serving as a Board Member at Egret Therapeutics and as Vice President & General Manager of the Soft Tissue, Aesthetic, and Reconstructive Business Unit at MTF Biologics. Previous roles include Interim Chief Executive Officer and Chief Operating Officer at OncoSec, Chief Executive Officer and Board Member at Alivio Therapeutics, and Chief Executive Officer and Co-Founder at Edge Therapeutics, where significant advancements in clinical studies were achieved. Leuthner's earlier positions include leadership roles at Fontus Pharmaceuticals, The Medicines Company, ESP Pharma, Cardinal Health, and Ortho Biotech. Brian Leuthner holds an MBA from UNC Kenan-Flagler Business School and a Bachelor's degree in Business Administration from the University of North Carolina at Chapel Hill.